[1]刘洛辰,刘小菡,张红婧,等.司库奇尤单抗治疗红皮病型银屑病2例[J].中国皮肤性病学杂志,2021,(01):116-fdfb2e49-98c8-40b8-a452-8972ae92d796/pdf.[doi:10.13735/j.cjdv.1001-7089.202005115]

点击复制

司库奇尤单抗治疗红皮病型银屑病2例

分享到：

参考文献/References:

[1] Menter A,Strober BE,Kaplan DH,et al.Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics[J].J Am Acade Dermatol,2019,80(4):1029-1072.
[2] Weng HJ,Wang TS,Tsai TF. Clinical experience of secukinumab in the treatment of erythrodermic psoriasis:a case series[J].Br J Dermatol,2018,178(6):1439-1440.
[3] Shibata T,Muto J,Takama H,et al.Case of psoriatic erythroderma induced by the discontinuation of the chronic use of topical steroid after dialysis initiation and successfully treated with secukinumab[J].J Dermatol,2019,46(4):e119-e120.
[4] 中华医学会皮肤性病学分会,中国医师协会皮肤科医师分会,中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物治疗专家共识(2019)[J].中华皮肤科杂志,2019,52(12):863-871.
[5] Dogra S,Bishnoi A,Narang T,et al.Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis[J].Dermatol Ther,2018,31(4):e12611.
[6] Mugheddu C,Atzori L,Lappi A,et al.Successful Secukinumab treatment of generalized pustular psoriasis and erythrodermic psoriasis[J].J Eur Acad Dermatol Venereol,2017,31(9):e420-e421.
[7] Mateu-Puchades A,Santos-Alarcón S,Martorell-Calatayud A,et al.Erythrodermic psoriasis and secukinumab:our clinical experience[J].Dermatol Ther,2018,31(4):e12607.